Novita Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Novita has a Fascin Inhibitor, NP-G2-044, which is a first-in-class, novel MOA that acts to inhibit metastasis and modulate immune function of Dendritic Cells resulting in synergy with PD-1 inhibitors, in almost all solid tumors. Currently in Phase 2a
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}